Intriguingly, our analysis unveiled a significant correlation between a high CDC42 expression in tumor tissues and increased mortality rates in TNBC patients compared to all breast cancer patients (Figure S6 and Figure 6D). The gene discussed is CDC42; the disease is breast cancer.